Petco Investor Day Presentation Deck
Reaffirming 2022 Guidance
2022
GUIDANCE
Net Revenue ($B)
Adj. EBITDA¹ ($B)
Adj. EPS²
Capital Expenditures
$6.15B-6.25B
$630M-645M
$0.97-1.00
$275-325M
petco
THE HEALTH + WELLNESS CO.
2 Guidance as of March 8, 2022. All guidance is subject to change without notice depending on a number of factors, including economic conditions, currency rates, the tax and regulatory landscape and
other factors that are beyond Petco's control.Petco undertakes no obligation to affirmor update its guidance.
I may be
small,
way lowe
Strong Top Line Growth and Operating Leverage is Expected to Translate to Strong Bottom Line Growth
1 We have not reconciled Adjusted EBITDA and Adjusted EPS outlook to the most comparable GAAP outlook because it is not possible to do so without unreasonable efforts due to the uncertainty and
potential variability of reconciling items, which are dependent on future events and often outside of management's control and which could be significant. Because such items cannot be reasonably
predicted with the level of precision required, we are unable to provide outlook for the comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA and Adjusted EPS are made in a
manner consistent with the relevant definitions and assumptions noted herein.View entire presentation